Please login to the form below

Not currently logged in
Email:
Password:

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Deal Watch table for December 2014

Deal Watch tableTable listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during December 2014

deal watch image mergers acquisitions pharmaDeal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

The impending threat of antibiotic resistance

Can Cinderella save us?Antibiotic Research UK is the BIA's charity of 2015, but what does it intend to do?

Webinars

Is co-creation the key to customer-centricity?

As pharma grapples with the need to becomemore doctor- and patient-centric, can co-creation help it better engage andconnect with its audience by redefining industry relationships with physicians and improve patient

Holistic market access and the importance of early engagement

Holistic market accessThere are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a

Digital: Fallacy or the Future Face of Pharma Marketing?

Digital: Fallacy or the Future Face of Pharma MarketingReach is one thing, trust is another. Digital channels may well be are growing in reach, but recent research from Cello Health Insight found that when it comes to trust,

UK payer perspectives: Is big data the future of market access?

'UK payer perspectives: Is big data the future of market access?’ will feature Paul Sutton, Director of Outcomes and Value, Commercial UK at Quintiles and Dr Junaid Bajwa, a GP

Country reports

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Creating a 21st century life sciences ecosystem

UK life sciences minister George FreemanThe UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation

Video

The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

Free White Paper: Customer Experience for Pharma

To learn why an effective customer experience strategy is vital for pharma, download our white paper “Customer experience for pharma” to learn more.

How ethical is your brand plan? Introducing the hEQ.

Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers.

Why e-detailing must give options to healthcare professionals

We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible.

Ed Schoonveld - new article

Following the publication of the new edition of The Price of Global Health, Ed Schoonveld writes about the industry's need for new drug pricing model.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ruder Finn UK Ltd

We are Ruder Finn A team of storytellers, digital makers and communicators In 2013 we grew by 20%. We recruited...